£101.65

Springer Cancer Immunology and Immunotherapy: 344 (Current Topics in Microbiology and Immunology, 344)

Price data checked 6 days ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£102 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 85 days · 85 data points (no recent data)

Historical
Generating forecast…
£101.65 £96.57 £98.60 £100.63 £102.67 £104.70 £106.73 07 June 2026 28 June 2026 19 July 2026 09 August 2026 30 August 2026

Price Distribution

Price distribution over 85 days • 1 price levels

Days at Price
85 days 0 21 43 64 85 £102 Days at Price

Price Analysis

Most common price: £102 (85 days, 100.0%)

Price range: £102 - £102

Price levels: 1 different prices over 85 days

Description

The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Current active immunotherapy trials have shown durable tumor regressions in a fraction of patients. However, clinical efficacy of current vaccines is limited, possibly because tumors skew the immune system by means of myeloid-derived suppressor cells, inflammatory type 2 T cells and regulatory T cells (Tregs), all of which prevent the generation of effector cells. To improve the clinical efficacy of cancer vaccines in patients with metastatic disease, we need to design novel and improved strategies that can boost adaptive immunity to cancer, help overcome Tregs and allow the breakdown of the immunosuppressive tumor microenvironment.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Innate and Adaptive Immunity in the Tumor Microenvironment: 1
88% match

Innate and Adaptive Immunity in the Tumor Microenvironment: 1

Springer

£76.42 13 Aug 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
87% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£113.76 06 Aug 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
87% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£108.01 10 Aug 2026
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
85% match

Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal

Springer

£179.99 06 Aug 2026
Cancer Immunotherapy: Paradigms, Practice and Promise
85% match

Cancer Immunotherapy: Paradigms, Practice and Promise

Springer

£108.01 06 Aug 2026
Cancer Immunotherapy: Immune Suppression and Tumor Growth
84% match

Cancer Immunotherapy: Immune Suppression and Tumor Growth

Academic Press

£88.00 13 Aug 2026
Inflammation, Infection, and Microbiome in Cancers: Evidence, Mechanisms, and Implications (Physiology in Health and Disease)
84% match

Inflammation, Infection, and Microbiome in Cancers: Evidence, Mechanisms, and Implications (Physiology in Health and Disease)

Springer

£108.91 08 Aug 2026
Immunotherapy for Pediatric Malignancies
84% match

Immunotherapy for Pediatric Malignancies

Springer

£113.90 08 Aug 2026
Cancer Immunology: 30 (Immunology and Medicine, 30)
83% match

Cancer Immunology: 30 (Immunology and Medicine, 30)

Springer

£113.76 08 Aug 2026
Tumor Microenvironment: The Role of Chemokines – Part A: 1231 (Advances in Experimental Medicine and Biology, 1231)
83% match

Tumor Microenvironment: The Role of Chemokines – Part A: 1231 (Advances in Experimental Medicine and Biology, 1231)

Springer

£108.01 08 Aug 2026
Attempts to Understand Metastasis Formation II: Regulatory Factors: 213/2 (Current Topics in Microbiology and Immunology, 213/2)
83% match

Attempts to Understand Metastasis Formation II: Regulatory Factors: 213/2 (Current Topics in Microbiology and Immunology, 213/2)

Springer

£76.42 19 Aug 2026
General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology
83% match

General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology

Springer

£149.86 04 Aug 2026
Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy: 9 (Resistance to Targeted Anti-Cancer Therapeutics, 9)
82% match

Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy: 9 (Resistance to Targeted Anti-Cancer Therapeutics, 9)

Springer

£75.14 12 Aug 2026
Tumor Microenvironment: Cellular, Metabolic and Immunologic Interactions: 1350 (Advances in Experimental Medicine and Biology, 1350)
82% match

Tumor Microenvironment: Cellular, Metabolic and Immunologic Interactions: 1350 (Advances in Experimental Medicine and Biology, 1350)

Springer

£129.92 08 Aug 2026
Immunotherapy for Gastrointestinal Cancer
82% match

Immunotherapy for Gastrointestinal Cancer

Springer

£99.11 08 Aug 2026
Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)
82% match

Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)

Humana

£108.01 06 Aug 2026
Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)
82% match

Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)

Humana

£37.01 10 Aug 2026
Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research, 14)
82% match

Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research, 14)

Springer

£164.55 07 Aug 2026
Immuno-Oncology: From Bench to Bedside
82% match

Immuno-Oncology: From Bench to Bedside

CREATESPACE

£82.80 13 Aug 2026
Immune Metabolism in Health and Tumor: 1011 (Advances in Experimental Medicine and Biology, 1011)
82% match

Immune Metabolism in Health and Tumor: 1011 (Advances in Experimental Medicine and Biology, 1011)

Springer

£92.22 05 Aug 2026
The Chemokine System in Experimental and Clinical Hematology: 341 (Current Topics in Microbiology and Immunology, 341)
82% match

The Chemokine System in Experimental and Clinical Hematology: 341 (Current Topics in Microbiology and Immunology, 341)

Springer

£108.01 20 Aug 2026
NK Cells in Cancer Immunotherapy: Successes and Challenges (Volume 4) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 4)
81% match

NK Cells in Cancer Immunotherapy: Successes and Challenges (Volume 4) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 4)

Elsevier

£119.39 05 Aug 2026
Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms and Therapy: 1248 (Advances in Experimental Medicine and Biology, 1248)
81% match

Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms and Therapy: 1248 (Advances in Experimental Medicine and Biology, 1248)

Springer

£142.76 04 Aug 2026
Selected Aspects of Cancer Progression: Metastasis, Apoptosis and Immune Response: 11 (Cancer Growth and Progression, 11)
81% match

Selected Aspects of Cancer Progression: Metastasis, Apoptosis and Immune Response: 11 (Cancer Growth and Progression, 11)

Springer

£108.01 04 Aug 2026